多菌株益生菌SYN-53在过敏犀牛结膜炎管理中的作用
Karl-Christian Bergmann1,2,3, Torsten Zuberbier1,2,3
1Institute of Allergology, Charité Universitätsmedizin, Berlin, Germany.
这项研究发现,益生菌SYN-53在两次治疗周期后显著降低了过敏犀牛结膜炎 (ARC) 的症状. SYN-53提供了ARC的有效管理策略,强调了益生菌在过敏治疗中的重要性.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 过敏学 过敏学
背景情况:
- 肠道失调症越来越多地与过敏性疾病的发展有关.
- 过敏性犀牛结膜炎 (ARC) 是一种常见的过敏状况,影响全球许多人.
- 益生菌正在被探索其调节免疫反应和管理过敏的潜力.
研究的目的:
- 评估多菌株益生菌SYN-53在管理过敏犀牛结膜炎 (ARC) 症状方面的疗效.
- 评估SYN-53对草花粉过敏患者症状严重程度和缓解的影响.
主要方法:
- 84名确诊患有草花粉过敏的受试者参与了这项研究.
- 试验对象每两周接受多达三次为期三天的SYN-53或安慰剂摄入周期.
- 在控制室中暴露于过敏原后,使用总症状评分 (TSS) 评估ARC症状.
主要成果:
- 在一个周期后,SYN-53表现出比安慰剂更大的疗效趋势,在两个周期后变得显著 (38%对24%的症状缓解).
- 在中度至重度症状的受试者中,SYN-53在一个周期后显示出显著的优势 (45%对26%的症状缓解),并在两个周期后进一步改善.
- 该研究强调,SYN-53显著减少了ARC症状,特别是在更严重的病例中.
结论:
- 多菌株益生菌SYN-53在过敏犀牛结膜炎的治疗中有效.
- 这些发现强调了细菌多样性和适当剂量在过敏管理中的益生菌补充剂中的作用.
- SYN-53为患有ARC的个人提供了一个有前途的治疗选择.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Drug Reactions
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
